Novel sustained release pharmaceutical compounds to prevent abuse of controlled substances
Details for Australian Patent Application No. 2003219863 (hide)
International Classifications
Event Publications
31 July 2003 Complete Application Filed
Priority application(s): 60/358,368 22.02.02 US; 60/362,082 07.03.02 US
16 October 2003 Application Open to Public Inspection
Published as AU-B-2003219863
23 October 2003 Application Open to Public Inspection
Published as AU-B-2003219863
24 January 2008 Assignment before Grant
New River Pharmaceuticals Inc. The application has been assigned to Shire LLC
31 July 2008 Application Accepted
Published as AU-B-2003219863
13 November 2008 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 17 Oct 2008. Address for service in Australia - FB Rice & Co Level 23 44 Market Street Sydney NSW 2000
5 March 2009 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 17 Oct 2008
12 March 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser